Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders

Cytokine & Growth Factor Reviews
Maurizio Pacifici, Eileen M Shore

Abstract

Activin receptor-like kinase-2 (ALK2), the product of ACVR1, is a member of the type I bone morphogenetic protein (BMP) receptor family. ALK2 exerts key and non-redundant roles in numerous developmental processes, including the specification, growth and morphogenesis of endochondral skeletal elements. There is also strong evidence that BMP signaling plays important roles in determination, differentiation and function of neural cells and tissues. Here we focus on the intriguing discovery that common activating mutations in ALK2 occur in Fibrodysplasia Ossificans Progressiva (FOP) and Diffuse Intrinsic Pontine Gliomas (DIPGs), distinct pediatric disorders of significant severity that are associated with premature death. Pathogenesis and treatment remain elusive for both. We consider recent studies on the nature of the ACVR1 mutations, possible modes of action and targets, and plausible therapeutic measures. Comparisons of the diverse - but genetically interrelated - pathologies of FOP and DIPG will continue to be of major mutual benefit with broad biomedical and clinical relevance.

References

Nov 1, 1991·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·P E DiCesareD T Cheung
Jan 1, 1986·Journal of Neurosurgery·F Epstein, E L McCleary
Oct 1, 1980·Experimental Cell Research·M PacificiF Tato
Jun 1, 1994·International Journal of Epidemiology·C A Stiller, J Nectoux
Sep 10, 1999·Developmental Biology·Y MishinaR R Behringer
Feb 23, 2000·The Journal of Cell Biology·A D WestonT M Underhill
May 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·K NakashimaT Taga
Jul 3, 2002·Nature Reviews. Neuroscience·Nicolas BertrandFrançois Guillemot
Jul 10, 2002·The Journal of Cell Biology·Andrea D WestonT Michael Underhill
Aug 17, 2002·The Journal of Pharmacology and Experimental Therapeutics·Jeanette WoodJonathan R Green
Apr 30, 2003·The Journal of Cell Biology·Andrea D WestonT Michael Underhill
May 16, 2003·Nature·Henry M Kronenberg
Jun 10, 2003·Journal of Pediatric Endocrinology & Metabolism : JPEM·A NogueraE González
Jun 11, 2003·The Journal of Cell Biology·Prithi RajanRonald D G McKay
Jun 18, 2003·Cell·Yigong Shi, Joan Massagué
Sep 13, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Donghui ZhangRegis J O'Keefe
Mar 24, 2004·Mechanisms of Development·Marek DudasVesa Kaartinen
Aug 20, 2004·Pharmacological Reviews·Daniel L SimmonsTimothy Hla
Oct 7, 2004·Developmental Biology·Xiao Huang, Jean-Pierre Saint-Jeannet
Dec 29, 2004·Growth Factors·Di ChenGregory R Mundy
Feb 16, 2006·The Oncologist·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 3, 2006·The Lancet Oncology·Darren HargraveEric Bouffet
Apr 11, 2006·Genesis : the Journal of Genetics and Development·Tomokazu FukudaYuji Mishina
Jul 5, 2006·The Journal of Cell Biology·Lisa M HoffmanT Michael Underhill
Nov 15, 2007·Nature Reviews. Molecular Cell Biology·Bernhard Schmierer, Caroline S Hill
Nov 21, 2007·Nature Chemical Biology·Paul B YuRandall T Peterson
Feb 5, 2008·The Journal of Bone and Joint Surgery. American Volume·Gregory K DeirmengianFrederick S Kaplan
Mar 11, 2008·Best Practice & Research. Clinical Rheumatology·Frederick S KaplanEileen M Shore
Jun 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anastasia MuratMonika E Hegi
Jun 21, 2008·Investigative Ophthalmology & Visual Science·Ramya RajagopalDavid C Beebe
Jul 16, 2008·Bioorganic & Medicinal Chemistry Letters·Gregory D CunyRandall T Peterson

❮ Previous
Next ❯

Citations

Dec 21, 2017·Intractable & Rare Diseases Research·Zijuan QiJinxiang Han
Jul 23, 2019·Proteomics·Ryan J DuchatelMatthew D Dun
Nov 7, 2019·Cells·José Antonio ValerFrancesc Ventura
Mar 3, 2020·Chemical & Pharmaceutical Bulletin·Katsuhiko SekimataNaoki Sakai
Mar 5, 2019·Chemical & Pharmaceutical Bulletin·Katsuhiko SekimataHiroo Koyama
Jun 3, 2016·Cold Spring Harbor Perspectives in Biology·Takenobu Katagiri, Tetsuro Watabe
Nov 8, 2018·Oncogene·Laura AsnaghiCharles G Eberhart
Feb 11, 2021·Biomedicines·Roberto Ravazzolo, Renata Bocciardi
Feb 19, 2021·Proceedings of the National Academy of Sciences of the United States of America·Abdul HaseebVéronique Lefebvre
Mar 7, 2021·Biomedicines·Francesc VenturaGonzalo Sanchez-Duffhues
Aug 18, 2021·Nature Communications·Christopher AgnewNatalia Jura

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
Frederick S Kaplan, R M Smith
© 2022 Meta ULC. All rights reserved